Insmed Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Pharmaceutical Investing
Sanofi: Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Bioverativ Pharmaceutical Investing
Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2017 Financial Results Pharmaceutical Investing
Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial Pharmaceutical Investing
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 Life Science Investing
Dermira Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update Biotech Investing
Adamas Reports Recent Achievements and Financial Results for the Fourth Quarter and Full-Year 2017 Life Science Investing
Apellis Pharmaceuticals Announces 18-Month Results of Phase 2 Study (FILLY) of APL-2 in Geographic Atrophy Biotech Investing
GW Pharmaceuticals Announces Preliminary Results of Phase 2a Study for its Pipeline Compound GWP42006 Biotech Investing
InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
